Summary of Study ST001226
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR000822. The data can be accessed directly via it's Project DOI: 10.21228/M8F69D This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
Study ID | ST001226 |
Study Title | Aquamin and Prevention of Colon Cancer (part-II) |
Study Type | MS analysis |
Study Summary | We propose to evaluate microbial and metabolic profiles in baseline and endpoint colonic mucosal, fecal, and serum samples from human patients at risk for CRC and enrolled in a 90-day phase I clinical trial. Patients will receive daily supplementation with calcium alone, a calcium-rich multimineral (Aquamin?), or placebo (maltodextrin) (n=10 per group). We hypothesize that dietary supplementation will correlate with CRC-protective metabolic profiles and that multimineral supplementation will generate more favorable profiles than calcium supplementation alone. |
Institute | University of Michigan |
Department | Biomedical Research Core Facilities |
Laboratory | Metabolomics core |
Last Name | Kachman |
First Name | Maureen |
Address | Ann Arbor, MI |
mkachman@med.umich.edu | |
Phone | 734-232-0842 |
Submit Date | 2019-07-23 |
Num Groups | 24 |
Total Subjects | 18 |
Study Comments | Colorectal cancer (CRC) is the third most common cancer and the second leading cause of cancer related death when both genders are combined. Epidemiologically, calcium intake has been protective against colonic adenomas and even colon cancer. Calcium supplementation has reduced the risk of colon adenoma formation in subjects with a history of previous colon polyps. The utility of calcium supplementation for colon cancer prevention is somewhat modulated by the modest or inconsistent level of protection afforded. Our preliminary data in mice and human enterocyte models shows that dietary supplementation with a multimineral supplement (Aquamin?) containing calcium in combination with 72 measureable trace minerals is more protective against tumors and epithelial growth dysregulation than calcium alone. One potential mechanism, supported by our rodent data, is that multimineral supplementation alters gut microbial populations to generate bile acid and short chain fatty acid (SCFA) profiles that are CRC-protective. |
Raw Data Available | Yes |
Analysis Type Detail | LC-MS |
Release Date | 2019-09-23 |
Release Version | 1 |
Select appropriate tab below to view additional metadata details:
Project:
Project ID: | PR000822 |
Project DOI: | doi: 10.21228/M8F69D |
Project Title: | Aquamin and Prevention of Colon Cancer |
Project Type: | MS analysis |
Project Summary: | Effects of calcium and multi-mineral supplementation on gut microbes and microbially-derived metabolites in patients at risk for colon cancer |
Institute: | University of Michigan |
Department: | Pathology |
Laboratory: | Aslam Lab |
Last Name: | Aslam |
First Name: | Muhammad Nadeem |
Address: | Ann Arbor, MI |
Email: | mnaslam@umich.edu |
Phone: | 734-936-1897 |
Subject:
Subject ID: | SU001293 |
Subject Type: | HUMAN |
Subject Species: | Homo sapiens |
Taxonomy ID: | 9606 |
Species Group: | Mammals |
Factors:
Subject type: HUMAN; Subject species: Homo sapiens (Factor headings shown in green)
mb_sample_id | local_sample_id | Time Point |
---|---|---|
SA086897 | S00031813 | Baseline |
SA086898 | S00031811 | Baseline |
SA086899 | S00031810 | Baseline |
SA086900 | S00031814 | Baseline |
SA086901 | S00031815 | Baseline |
SA086902 | S00031799 | Baseline |
SA086903 | S00031816 | Baseline |
SA086904 | S00031809 | Baseline |
SA086905 | S00031812 | Baseline |
SA086906 | S00031803 | Baseline |
SA086907 | S00031802 | Baseline |
SA086908 | S00031808 | Baseline |
SA086909 | S00031800 | Baseline |
SA086910 | S00031804 | Baseline |
SA086911 | S00031801 | Baseline |
SA086912 | S00031805 | Baseline |
SA086913 | S00031806 | Baseline |
SA086914 | S00031807 | Baseline |
SA086915 | S00031830 | Day 90 |
SA086916 | S00031828 | Day 90 |
SA086917 | S00031829 | Day 90 |
SA086918 | S00031831 | Day 90 |
SA086919 | S00031833 | Day 90 |
SA086920 | S00031827 | Day 90 |
SA086921 | S00031834 | Day 90 |
SA086922 | S00031832 | Day 90 |
SA086923 | S00031817 | Day 90 |
SA086924 | S00031820 | Day 90 |
SA086925 | S00031819 | Day 90 |
SA086926 | S00031818 | Day 90 |
SA086927 | S00031821 | Day 90 |
SA086928 | S00031822 | Day 90 |
SA086929 | S00031825 | Day 90 |
SA086930 | S00031824 | Day 90 |
SA086931 | S00031823 | Day 90 |
SA086932 | S00031826 | Day 90 |
Showing results 1 to 36 of 36 |
Collection:
Collection ID: | CO001287 |
Collection Summary: | Not available. |
Sample Type: | Blood (serum) |
Treatment:
Treatment ID: | TR001308 |
Treatment Summary: | Not available. |
Sample Preparation:
Sampleprep ID: | SP001301 |
Sampleprep Summary: | Two-step solvent extraction. Supernatants are combined, dried, and re-suspended for LCMS separation by RPLC and measurements by ESI- QQQ MRM methods. Analytes are reported as uM, and CV's are generally <15%. |
Sampleprep Protocol Filename: | Bile_acids_analysis.doc |
Combined analysis:
Analysis ID | AN002039 |
---|---|
Analysis type | MS |
Chromatography type | Reversed phase |
Chromatography system | Agilent 1260 |
Column | Waters Acquity BEH C18 (50 x 2mm,1.7um) |
MS Type | ESI |
MS instrument type | Triple quadrupole |
MS instrument name | Agilent 6490 QQQ |
Ion Mode | POSITIVE |
Units | uM |
Chromatography:
Chromatography ID: | CH001479 |
Methods Filename: | 2014-07-30-Bile_acid-full-BEH-C18-I.m.zip |
Instrument Name: | Agilent 1260 |
Column Name: | Waters Acquity BEH C18 (50 x 2mm,1.7um) |
Chromatography Type: | Reversed phase |
MS:
MS ID: | MS001891 |
Analysis ID: | AN002039 |
Instrument Name: | Agilent 6490 QQQ |
Instrument Type: | Triple quadrupole |
MS Type: | ESI |
MS Comments: | NA |
Ion Mode: | POSITIVE |
Acquisition Parameters File: | 2014-07-30-Bile_acid-full-BEH-C18-I.m.zip |